LIPVAS F 10 TABS

Description

LIPVAS F 10 Tablet, manufactured by Cipla Ltd, is a combination medicine that contains Atorvastatin (10mg) and Fenofibrate (160mg). It belongs to the class of medicines used for cholesterol and lipid management, particularly in patients who need dual therapy to control both cholesterol and triglycerides.

• Atorvastatin (10mg) is a statin that works by reducing the production of cholesterol in the liver. It lowers LDL (bad cholesterol) and triglycerides, while increasing HDL (good cholesterol), thus preventing plaque buildup in the arteries.

• Fenofibrate (160mg) belongs to the fibrate group of medicines. It is especially effective in lowering triglyceride levels and improving the breakdown of fats in the blood.

The combination of these two medicines makes LIPVAS F 10 highly effective in managing mixed dyslipidemia (high cholesterol + high triglycerides) and in reducing the risk of atherosclerosis, heart attack, and stroke.

Uses of LIPVAS F 10:

• Treatment of mixed dyslipidemia

• Control of high cholesterol and high triglyceride levels

• Prevention of cardiovascular diseases in high-risk patients

• Management of lipid disorders in patients not adequately controlled with statin therapy alone

Key Benefits:

• Dual action on cholesterol and triglycerides

• Lowers LDL (bad cholesterol)

• Raises HDL (good cholesterol)

• Reduces triglyceride levels effectively

• Helps prevent artery blockage and cardiovascular complications

Important Information:

• LIPVAS F 10 should be taken once daily, with or without food, as prescribed by the doctor.

• Along with this medicine, patients must follow a low-fat diet, regular exercise, weight management, and healthy lifestyle habits for best results.

• Common side effects may include stomach pain, nausea, headache, constipation, muscle pain, or weakness.

• Rarely, it may cause liver enzyme changes or severe muscle problems (myopathy/rhabdomyolysis). Regular blood tests for liver function, kidney function, and lipid profile may be required.

• Patients should avoid excessive alcohol intake while on this medicine, as it can increase the risk of liver and muscle-related side effects.

• It is not recommended in patients with severe liver, kidney, or gallbladder disease.

In conclusion, LIPVAS F 10 (Atorvastatin 10mg + Fenofibrate 160mg, by Cipla Ltd) is an effective combination therapy for patients with both high cholesterol and high triglyceride levels, offering better cardiovascular protection than single-drug therapy when used under medical supervision.